SAN JOSE, Calif. - Rani Therapeutics Holdings , Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company with a market capitalization of $48.3 million, today announced promising results from a ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 64 figures, this 150-page report Asia Pacific Digital Health and Wellness Market 2023-2033 by Product ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 88 tables and 97 figures, this 206-page report Global Digital Health and Wellness Market 2023-2033 by Product (Hardware, ...

Major employers and innovators recognised at ceremony showcasing Ireland’s pharmaceutical leadership, as sector marks record ...